Spruce Biosciences
Stock Forecast, Prediction & Price Target
Spruce Biosciences Financial Estimates
Spruce Biosciences Revenue Estimates
Spruce Biosciences EBITDA Estimates
Spruce Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $10.08M 0% | Avg: $2.38M Low: $2.33M High: $2.43M avg. -76.35% | Avg: $3.3M Low: $1.78M High: $4.52M avg. 38.32% | Avg: $10.75M Low: $5.81M High: $14.74M avg. 225.75% | Avg: $52.87M Low: $28.60M High: $72.54M avg. 391.89% |
Net Income
% change YoY
| $-42.68M N/A | $-45.07M -5.59% | $-47.91M -6.30% | Avg: $-52.78M Low: $-54.68M High: $-21.18M avg. -10.15% | Avg: $-65.15M Low: $-61.61M High: $-16.94M avg. -23.42% | Avg: $-47.94M Low: $-71.13M High: $-19.32M avg. 26.41% | Avg: $-20.02M Low: $-29.70M High: $-8.07M avg. 58.23% |
EBITDA
% change YoY
| $-41.94M N/A | $-45.76M -9.09% | $-47.36M -3.50% | Avg: $1.43M Low: $1.40M High: $1.45M avg. 103.02% | Avg: $1.98M Low: $1.07M High: $2.71M avg. 38.32% | Avg: $6.45M Low: $3.48M High: $8.84M avg. 225.75% | Avg: $31.72M Low: $17.16M High: $43.52M avg. 391.89% |
EPS
% change YoY
| -$1.83 N/A | -$1.92 -4.91% | -$1.24 35.41% | Avg: -$0.94 Low: -$1.42 High: -$0.55 avg. 24.32% | Avg: -$0.87 Low: -$1.6 High: -$0.44 avg. 7.54% | Avg: -$1.25 Low: -$1.85 High: -$0.5 avg. -43.51% | Avg: -$0.52 Low: -$0.77 High: -$0.21 avg. 58.23% |
Operating Expenses
% change YoY
| $42.06M N/A | $47.28M 12.40% | $62.08M 31.29% | Avg: $2.50M Low: $2.45M High: $2.55M avg. -95.96% | Avg: $3.46M Low: $1.87M High: $4.75M avg. 38.32% | Avg: $11.28M Low: $6.10M High: $15.47M avg. 225.75% | Avg: $55.49M Low: $30.01M High: $76.13M avg. 391.89% |
FAQ
What is Spruce Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 12.76% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -54.68M, average is -52.78M and high is -21.18M.
What is Spruce Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 144.90% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $2.33M, average is $2.38M and high is $2.43M.
What is Spruce Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 11.64% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.42, average is -$0.94 and high is $-0.55.